Deutsche Bank Aktiengesellschaft Reiterates Hold Rating for Dr. Martens (LON:DOCS)

Dr. Martens (LON:DOCS)‘s stock had its “hold” rating reissued by stock analysts at Deutsche Bank Aktiengesellschaft in a research note issued on Friday, Marketbeat.com reports.

Separately, Royal Bank Of Canada decreased their price objective on shares of Dr. Martens from GBX 7,000 ($93.72) to GBX 6,000 ($80.33) and set a “sector perform” rating for the company in a research note on Monday, May 19th.

Dr. Martens Trading Down 1.1%

Shares of LON:DOCS traded down GBX 0.85 ($0.01) during trading on Friday, reaching GBX 78.50 ($1.05). The company’s stock had a trading volume of 836,571 shares, compared to its average volume of 2,137,253. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. Dr. Martens has a 12 month low of GBX 43.02 ($0.58) and a 12 month high of GBX 83.30 ($1.12). The firm’s 50 day simple moving average is GBX 68.52 and its two-hundred day simple moving average is GBX 64.02. The stock has a market capitalization of £762.05 million, a PE ratio of 11.13, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS) last announced its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, research analysts predict that Dr. Martens will post 2.5809394 EPS for the current fiscal year.

Dr. Martens Company Profile

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.